Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 207533 / DOSAGE - SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 662MG/2.4ML (275.83MG/ML)
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| aripiprazole lauroxil(UNII: B786J7A343) (aripiprazole lauroxil - UNII:B786J7A343) | aripiprazole lauroxil | 882mg in 3.2 | 1064mg in 3.9 | 441mg in 1.6 | 662mg in 2.4 |
Inactive Ingredients
| Ingredient Name | Alkermes, Inc. |
|---|---|
| Polysorbate 20(7T1F30V5YH) | |
| Sodium Chloride(451W47IQ8X) | |
| Sodium Phosphate, Dibasic, Anhydrous(22ADO53M6F) | |
| Sodium Phosphate, Monobasic, Dihydrate(5QWK665956) | |
| Sorbitan Monolaurate(6W9PS8B71J) | |
| Water(059QF0KO0R) |
